TG Therapeutics, Inc. (TGTX)
54.29
+0.67
(+1.25%)
USD |
NASDAQ |
Oct 02, 16:00
54.27
-0.02
(-0.04%)
After-Hours: 20:00
TG Therapeutics Market Cap : 8.311B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 8.311B |
| October 01, 2026 | 8.208B |
| September 30, 2026 | 8.539B |
| September 29, 2026 | 8.601B |
| September 28, 2026 | 8.601B |
| September 25, 2026 | 8.791B |
| September 24, 2026 | 8.805B |
| September 23, 2026 | 8.572B |
| September 22, 2026 | 8.895B |
| September 21, 2026 | 8.750B |
| September 18, 2026 | 8.706B |
| September 17, 2026 | 8.644B |
| September 16, 2026 | 8.549B |
| September 15, 2026 | 8.119B |
| September 14, 2026 | 8.266B |
| September 11, 2026 | 8.249B |
| September 10, 2026 | 8.479B |
| September 09, 2026 | 8.366B |
| September 08, 2026 | 8.533B |
| September 04, 2026 | 8.570B |
| September 03, 2026 | 8.681B |
| September 02, 2026 | 8.710B |
| September 01, 2026 | 8.586B |
| August 31, 2026 | 8.312B |
| August 28, 2026 | 8.255B |
| Date | Value |
|---|---|
| August 27, 2026 | 8.529B |
| August 26, 2026 | 8.424B |
| August 25, 2026 | 8.484B |
| August 24, 2026 | 8.574B |
| August 21, 2026 | 8.308B |
| August 20, 2026 | 7.740B |
| August 19, 2026 | 7.913B |
| August 18, 2026 | 7.694B |
| August 17, 2026 | 7.544B |
| August 14, 2026 | 7.461B |
| August 13, 2026 | 7.339B |
| August 12, 2026 | 7.577B |
| August 11, 2026 | 7.639B |
| August 10, 2026 | 7.525B |
| August 07, 2026 | 7.617B |
| August 06, 2026 | 7.585B |
| August 05, 2026 | 7.636B |
| August 04, 2026 | 7.460B |
| August 03, 2026 | 7.068B |
| July 31, 2026 | 7.965B |
| July 30, 2026 | 8.194B |
| July 29, 2026 | 8.187B |
| July 28, 2026 | 8.399B |
| July 27, 2026 | 8.534B |
| July 24, 2026 | 8.578B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Krystal Biotech, Inc. | 9.538B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| BioMarin Pharmaceutical, Inc. | 11.07B |
| Cytokinetics, Inc. | 9.103B |
| Exelixis, Inc. | 14.53B |
Market Cap Related Metrics
| PE Ratio | 19.77 |
| PS Ratio | 10.83 |
| PEG Ratio | 0.0312 |
| Price to Book Value | 13.76 |
| Price to Free Cash Flow | 497.86 |
| Price | 54.29 |
| Earnings Yield | 5.06% |
| PEGY Ratio | 0.0312 |
| Operating PE Ratio | 63.49 |
| Normalized PE Ratio | 19.40 |